well receipts from customers should at least double next quarter bringing it to 300k, given the product manufacturing and operating cost is doubling (expenses outlook). but company is still very top heavy. but I'm confident in the product and management to secure some big deals in 2020. happy to hold this at the current MC
- Forums
- ASX - By Stock
- 1CG
- for newbies (like me)
for newbies (like me), page-28
Featured News
Add 1CG (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $12.33M |
Open | High | Low | Value | Volume |
1.4¢ | 1.4¢ | 1.3¢ | $11.86K | 909.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 100000 | 1.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.4¢ | 1749431 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 100000 | 0.013 |
5 | 5383751 | 0.012 |
7 | 2890461 | 0.011 |
3 | 285564 | 0.010 |
2 | 514000 | 0.009 |
Price($) | Vol. | No. |
---|---|---|
0.014 | 1749431 | 2 |
0.015 | 4637987 | 5 |
0.016 | 4327563 | 5 |
0.017 | 3021158 | 8 |
0.018 | 150000 | 1 |
Last trade - 14.33pm 15/11/2024 (20 minute delay) ? |
Featured News
1CG (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online